C26H44O9
Neat
500.64
Mupirocin EP Impurity D; 71087-97-3; IR6520UV0B; 9-(((2E)-4-((2R, 3aS, 6S, 7S)-2-((2S, 3S)-1, 3-Dihydroxy-2-methylbutyl)-7-hydroxyhexahydro-4H-furo(3, 2-C)pyran-6-yl)-3-methylbut-2-enoyl)oxy)nonanoic acid; UNII-IR6520UV0B; Mupirocin calcium impurity D [EP]; MUPIROCIN IMPURITY D [EP IMPURITY]; G87737; MUPIROCIN CALCIUM IMPURITY D [EP IMPURITY]; Q27280861; 9-(((E)-4-((2R, 3aS, 6S, 7S)-2-((2S, 3S)-1, 3-dihydroxy-2-methylbutyl)-7-hydroxyhexahydro-4H-furo[3, 2-c]pyran-6-yl)-3-methylbut-2-enoyl)oxy)nonanoic acid; NONANOIC ACID, 9-((4-(2-(1, 3-DIHYDROXY-2-METHYLBUTYL)HEXAHYDRO-7-HYDROXY-4H-FURO(3, 2-C)PYRAN-6-YL)-3-METHYL-1-OXO-2-BUTENYL)OXY)-, (2R-(2.ALPHA.(1S*, 2S*, 3S*), 3A.BETA., 6.ALPHA.(E), 7.BETA., 7A.ALPHA.))-; Nonanoic acid, 9-((4-(2-(1, 3-dihydroxy-2-methylbutyl)hexahydro-7-hydroxy-4H-furo(3, 2-C)pyran-6-yl)-3-methyl-1-oxo-2-butenyl)oxy)-, (2R-(2alpha(1S*, 2S*, 3S*), 3abeta, 6alpha(E), 7beta and 7aalpha))-
9-[(E)-4-[(2R, 3aS, 6S, 7S)-2-[(2S, 3S)-1, 3-dihydroxy-2-methylbutyl]-7-hydroxy-3, 3a, 4, 6, 7, 7a-hexahydro-2H-furo[3 and 2-c]pyran-6-yl]-3-methylbut-2-enoyl]oxynonanoic acid
InChI=1S/C26H44O9/c1-16(13-23(30)33-11-9-7-5-4-6-8-10-22(28)29)12-20-25(32)26-19(15-34-20)14-21(35-26)24(31)17(2)18(3)27/h13,17-21,24-27,31-32H,4-12,14-15H2,1-3H3,(H,28,29)/b16-13+/t17-,18-,19-,20-,21+,24?,25-,26?/m0/s1